Jing Li

Acquired Resistance to Venetoclax plus Azacitidine in Acute Myeloid Leukemia: in vitro Models and Mechanisms.

X. Bao, J. Taub, M. Hüttemann, 2023, Biochemical pharmacology.

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.

M. Konopleva, X. Bao, J. Taub, 2023, Biochemical pharmacology.